Indaptus Therapeutics INDP
NASDAQ INDP
$2.99 -0.17 (-5.38%)
As of: Oct 22, 2026 · 2:10 PM EDT

Indaptus Therapeutics (INDP) EV to FCF (2021)

Updated

Indaptus Therapeutics' EV to FCF came in at 6.43 for Q2 2021, down 73.2% from the prior quarter.

Analysis

Indaptus Therapeutics (INDP) EV to FCF (2021) Analysis & Trends

Over the trailing twelve months to Jun 30, 2021, Indaptus Therapeutics reported EV to FCF of -12.24.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,170.64 Bn 1,139.23 Bn 19.71 Bn
2 Johnson & Johnson 647.91 Bn 567.77 Bn 17.30 Bn
3 AbbVie 503.02 Bn 476.13 Bn 12.70 Bn
4 Merck 365.11 Bn 319.49 Bn 12.21 Bn
5 Novartis Ag 303.38 Bn 267.37 Bn 11.24 Bn
6 Astrazeneca 268.87 Bn 242.56 Bn 12.86 Bn
7 Amgen 242.01 Bn 197.41 Bn 7.24 Bn
8 Gilead Sciences 194.74 Bn 168.94 Bn 6.22 Bn
9 Pfizer 172.37 Bn 119.01 Bn 10.94 Bn
10 Indaptus Therapeutics 191.70 Mn 164.31 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 6.43
Mar 31, 2021 23.95
API Access

Indaptus Therapeutics EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=INDP&period=max&api_key=YOUR_API_KEY